Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.25
-0.01 (-0.05%)
Nov 22, 2024, 4:00 PM EST - Market closed
Travere Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,588 | 676 | 1,350 | 1,900 | 1,391 | 610 | |
| Market Cap Growth | 59.58% | -49.94% | -28.99% | 36.58% | 128.10% | -34.65% | |
| Enterprise Value | 1,713 | 446 | 1,251 | 1,609 | 1,177 | 416 | |
| Last Close Price | 18.25 | 8.99 | 21.03 | 31.04 | 27.25 | 14.20 | |
| PS Ratio | 6.93 | 4.65 | 12.33 | 14.42 | 7.02 | 3.48 | |
| PB Ratio | -35.14 | 3.36 | 31.49 | 6.29 | 6.59 | 2.76 | |
| P/TBV Ratio | - | 7.01 | - | 12.37 | 24.37 | 9.67 | |
| EV/Sales Ratio | 8.42 | 3.07 | 11.43 | 12.21 | 5.93 | 2.37 | |
| Debt / Equity Ratio | -13.21 | 2.02 | 9.51 | 0.87 | 1.16 | 0.93 | |
| Asset Turnover | 0.30 | 0.20 | 0.15 | 0.19 | 0.33 | 0.27 | |
| Inventory Turnover | 16.58 | 36.81 | 39.16 | 27.47 | 20.15 | 24.99 | |
| Quick Ratio | 1.61 | 3.33 | 3.30 | 4.59 | 4.26 | 4.38 | |
| Current Ratio | 1.71 | 3.47 | 3.42 | 4.70 | 4.43 | 4.50 | |
| Return on Equity (ROE) | -279.94% | -308.90% | -192.18% | -84.66% | -78.37% | -54.29% | |
| Return on Assets (ROA) | -26.14% | -32.22% | -27.58% | -18.01% | -7.77% | -9.50% | |
| Return on Capital (ROIC) | -33.07% | -44.60% | -39.41% | -24.45% | -10.69% | -12.97% | |
| Earnings Yield | -22.13% | -16.49% | -20.63% | -9.48% | -12.18% | -24.00% | |
| FCF Yield | -17.15% | -41.55% | -13.82% | -1.05% | -3.56% | -9.58% | |
| Buyback Yield / Dilution | -8.47% | -16.48% | -6.56% | -25.86% | -12.28% | -4.72% | |
| Total Shareholder Return | -8.47% | -16.48% | -6.56% | -25.86% | -12.28% | -4.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.